Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19

Clinical trial NCT04661527 · UNKNOWN

Trial details

NCT number: NCT04661527
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Drug Treatment

Start date: 2020-04-22
Primary completion: 2020-12-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.